News

Preventing pressure injuries (bed sores)

Preventing-Pressure-Injuries-(Bed-Sores)

Martin Burns, CEO of BBI (Bruin Biometrics), discusses preventing pressure injuries, the recently updated guidelines by the National Pressure Injury (formerly Ulcer) Advisory Panel, and the financial impact of pressure injuries and how the system can incorporate major change.  After crunching the numbers, analyzing the data and developing technology to create a solution, he believes that true prevention of pressure injuries can finally be made real.  

Frequently Asked Questions

What is the main topic discussed in this episode of Health Professional Radio?

This episode covers important developments in healthcare, including updates on Prevention. Health Professional Radio brings you expert insights and analysis on the latest medical news affecting healthcare professionals and patients alike.

How can healthcare professionals benefit from this information?

Healthcare professionals can stay informed about the latest developments in Prevention and related fields, enabling them to provide better patient care. Staying current with medical news helps clinicians make evidence-based decisions in their practice.

Where can I find more information about Prevention?

For more detailed information, listen to the full episode on Health Professional Radio and visit hpr.fm for additional resources. You can also subscribe to our podcast for regular updates on healthcare news and expert interviews.

Appointed CEO in 2012, Martin established and led the successful journey of BBI’s SEM Scanner through FDA de novo Marketing Authorization (2018), CE Marking (2013) and the UK’s National Institute of Health and Care Excellence’ (NICE) Medical Innovation Briefing process (MIB 182, 2019). The device is the only FDA Authorized technology for the assessment of skin and tissue at risk for PI development; Authorization created the FDA’s classification for Pressure Ulcer/Injury Management Tools. The Scanner is widely commercially available in North America, Europe, and Australasia.

Martin is the co-author of 2 submitted manuscripts on PI prevention care-pathway analysis and the health-economic cost-consequences of technology-enabled prevention. He has presented real-world evidence and health-economic analysis in the academic tracks at the European Pressure Ulcer Advisory Panel meetings in 2017 and 2019, and in the Medical Device Development track at Advamed in 2018. Prestigious broadcast television networks and top-tier industry publications have interviewed Martin as a prevention expert and have featured his interviews and published his contributed articles as a guest author. Martin was a guest lecturer in Medical Marketing, Medical Device Development and Health System Economics at UCLA Anderson’s School of Management between May 2014-July 2017.  He is a named inventor on 4 issued patents and over 100 pending, published or registered patents globally, related to wound-device, orthopedic-device, care-pathway, and wound-data algorithms. Martin earned his BA (1996) at the London School of Economics and Political Science (LSE) and his MBA at UCLA’s Anderson School of Management (2007). Martin’s early career was as a consultant at Deloitte Consulting in the USA, PwC and Arthur Andersen in London.

Last updated: February 17, 2020

Medical Disclaimer

The information provided on this website is for general informational purposes only and is not intended as medical advice. Always consult with a qualified healthcare professional for medical advice, diagnosis, or treatment. Never disregard professional medical advice or delay in seeking it because of something you have read on this website.